Does EPCORITAMAB Cause Neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neoplasm progression have been filed in association with EPCORITAMAB (EPKINLY). This represents 0.5% of all adverse event reports for EPCORITAMAB.
10
Reports of Neoplasm progression with EPCORITAMAB
0.5%
of all EPCORITAMAB reports
5
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From EPCORITAMAB?
Of the 10 reports, 5 (50.0%) resulted in death, 6 (60.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB Cause?
Cytokine release syndrome (551)
Pyrexia (258)
Off label use (229)
Febrile neutropenia (219)
Pneumonia (154)
Covid-19 (125)
Sepsis (106)
Hypotension (95)
Diffuse large b-cell lymphoma (86)
Neutropenia (84)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which EPCORITAMAB Alternatives Have Lower Neoplasm progression Risk?
EPCORITAMAB vs EPCORITAMAB-BYSP
EPCORITAMAB vs EPERISONE
EPCORITAMAB vs EPHEDRINE
EPCORITAMAB vs EPINASTINE
EPCORITAMAB vs EPINEPHRINE